TOMSK, RUSSIA / RankWire.AI / – The laboratory tests revealed that human mesenchymal stem cells exhibited notably higher survival rates on coated titanium surfaces compared to uncoated samples, as demonstrated by Russian scientists. The research focused on a bioactive coating aimed at optimizing the interaction between titanium orthopaedic implants and bone tissue. This innovative material incorporates calcium phosphate derived from hydroxyapatite and includes nitrogen compounds linked to nitric oxide production. The team examined various aspects of the coating, including its structure, chemistry, mechanical properties, and biological response, with their peer-reviewed results published in Applied Surface Science in 2026.
At Tomsk Polytechnic University, scientists fabricated the experimental coatings by reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. During the process, they altered the nitrogen and argon gas ratios to observe how each mixture influenced the surface properties. Five different conditions were tested, ranging from pure nitrogen to pure argon. The team then assessed coating thickness, surface morphology, hardness, wettability, and chemical makeup. Additionally, laboratory tests evaluated how live human cells responded to the modified titanium surfaces.
The physical attributes of the coatings were affected by the argon content, with pure argon creating surfaces that were denser and harder than those deposited in pure nitrogen. As the proportion of argon increased, the coating thickness also grew. Chemical analysis identified nitrogen-carbon and nitrogen-oxygen bonds present on the modified surfaces. When comparing human mesenchymal stem cells grown on coated titanium to those on uncoated titanium, the biological tests focused on cell viability and markers associated with bone-cell development.
Enhanced Cell Viability Observed in Coated Samples
According to the study’s findings, cells showed significantly improved survival on coated surfaces compared to uncoated titanium. After a period of seven days, coatings with higher nitrogen levels also suppressed activity in certain genes linked to early bone-cell differentiation. Despite this, the cells maintained their capacity for bone formation. The research was conducted under controlled laboratory conditions using human mesenchymal stem cells, and did not involve testing the coating in clinical settings or evaluating the performance of actual medical implants in patients.
The biomedical evaluation was carried out by Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional contributions from Saint Petersburg State University. The project received support through Russia’s national science program. The researchers aimed to identify gas mixtures capable of producing coatings with desirable physical, chemical, and biological properties. Hydroxyapatite is already utilized in implant coatings due to its calcium phosphate composition, which resembles the mineral component of human bone.
Further Testing Still Pending
The team outlined plans for extended testing beyond the initial seven-day cell observation. Future research aims to analyze stem cell behavior over 10 to 28 days, examine the rate at which coatings dissolve, and measure nitric oxide release into tissues in living organisms. These additional experiments were not part of the current publication, which primarily focused on the in vitro responses of coated titanium substrates and their physical and chemical characteristics, without clinical trials involving orthopaedic patients.
The research provides detailed insights into how varying ratios of nitrogen and argon influence calcium phosphate coatings on titanium surfaces, highlighting differences in thickness, density, hardness, chemical bonds, and cellular responses across the tested gas mixtures. The results also confirm that coated samples support higher stem-cell survival than uncoated titanium in laboratory conditions. However, since the study remains at the preclinical stage, the experiments do not establish safety or efficacy for human use. Additional biological tests will be necessary to evaluate properties not covered in this study.